Randomized Controlled Trial on the Effect of Talapotichil against Takradhārā in the Management of Essential Hypertension

Abstract

Background

Hypertension (HTN) is one of the most common complex disorders. It is estimated that 1 billion people are affected by HTN worldwide. About 90 to 95% HTN is Essential Hypertension (EHTN). Even though there are a number of anti-hypertensive drugs many have side effects so there was an urgent need of formulating an effective management for EHTN, devoid of any complication. Talapotichil is a traditional treatment for EHTN being practiced widely. So this study was taken to compare the effect of Talapodichil in the management of EHTN against Takradhārā.

Aim and Objectives

To study the effect of talapotichil in the management of first stage of EHTN. 2) To study EHTN from Ayurvedic point of view.

Methods

20 patients diagnosed with 1ststage of EHTN (140/90<160/100mm of Hg) were randomly selected and allocated in to two groups, trial group and control Group and were treated with Talapotichil and Takradhārā respectively. The assessment criteria were Blood pressure and were measured before the treatment, after the last day of treatment and after 28 days of follow-up. Data were collected and statistically analysed.

Results

Even though the trial group showed highly significant reduction in both systolic and diastolic blood pressure after treatment and after follow up, the comparison with control group showed insignificant change except a significant reduction in diastolic BP after follow up.

Conclusions

Talapodichil and Takradhārā are equally effective in the management of EHTN. EHTN does not represent any single disease in Ayurveda but it can be treated on the basis of dosha-dushya vivechanā.